A 900 bp genomic region from the mouse dystrophin promoter directs lacZ reporter expression only to the right heart of transgenic mice

Development Growth and Differentiation

Volumn 39, Issue 3, 1997, Pages 257-265

  Kimura, Shigemi ^a   Abe, Kuniya ^a   Suzuki, Misao ^a   Ogawa, Masakatsu ^a   Yoshioka, Kowashi ^a   Kaname, Tadasi ^a   Miike, Teruhisa ^a   Yamamura, Ken Ichi ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Dystrophin; LacZ; Promoter; Right heart; Transgenic mouse

Indexed keywords

DYSTROPHIN;

ADOLESCENT; ANIMAL TISSUE; ARTICLE; BECKER MUSCULAR DYSTROPHY; DEVELOPMENT; DUCHENNE MUSCULAR DYSTROPHY; EMBRYO; GENE EXPRESSION; HEART; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROMOTER REGION; TRANSGENIC MOUSE;

ANIMALIA; BACTERIA (MICROORGANISMS); MUS MUSCULUS;

EID: 0030908315     PISSN: 00121592     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-169X.1997.t01-2-00001.x     Document Type: Article

References (34)

1. Ahn, A. H. & Kunkel, L. M. 1993. The structural and functional diversity of dystrophin. Nature Genet. 3, 283-291.
2. Allen, N. D., Cran, D. G., Barton, S. C., Hettle. S., Reik, W. & Surani, M. A. 1988. Transgenes as probes for active chromosomal domains in mouse development. Nature 333, 852-855.
3. Berko, B. A. and Swift, M. 1987. X-linked dilated cardiomyopathy. N. Engl. J. Med. 316, 1186.
4. Boyce, F. M., Beggs, A. H., Feener, C. & Kunkel, L. M. 1991. Dystrophin is transcribed in brain from a distant upstream promoter. Proc. Natl Acad. Sci. USA 88, 1276-1280.
5. Byers, T. J., Lidov, H. G. W. & Kunkel, L. M. 1993. An alternative dystrophin transcript specific to peripheral nerve. Nature Genet. 4, 77-81.
6. Chelly, J., Hamard, G., Kooulakoff, A., Kaplan, J-C., Kahn, A. & Berwald-Netter, Y. 1990 Dystrophin gene transcribed from different promoters in neuronal and glial cells. Nature 344, 64-65.
7. D'Souza, V. N., Man, N. T., Morris, G. E., Karges, W. & Pillers, D-A. M. 1995 A novel dystrophin isoform is required for normal retinal electrophysiology. Hum. Mol. Genet. 4, 837-842.
8. Forrest, S. M., Cross, G. S., Flint, T., Speer, A., Robson K. J. H. & Davies, K. E. 1988. Further studies of gene deletions that cause Duchenne and Backer muscular dystrophies Genomics 2, 109-114.
9. Gilgenkrantz, H., Hugnot, J-P., Lambert, M., Chafey, P., Kaplan, J-C. & Kahn, A. 1992. Positive and negative regulatory DNA elements including a CCarGG box are involved in the cell type-specific expression of the human muscle dystrophin gene. J. Biol. Chem. 267, 10823-10830.
10. Gorecki, D. C., Monaco, A. P., Derry, J. M. J., Walker, A. P., Barnard, E. A. & Barnard, P. J. 1992. Expression of four alternative dystrophin transcripts in brain regions regulated by different promoters. Hum. Mol. Genet. 1, 505-510.
11. Hoffman, E. P., Brown, R. H. J. & Kunkel, L. M. 1987. Dystrophin: The protein product of the Duchenne muscular dystrophy locus. Cell 51, 919-928.
12. Hunsker, R. H., Fulkerson, P. K., Barry, F. J., Lewis, R. P., Leier, C. V. & Unverferth, D. V. 1982. Cardiac function in Duchenne's muscular dystrophy: Results of 10-year follow-up study and non-inactive tests. Am. J. Med. 73, 235-238.
13. Iannello, R. C., Mar, J. H. & Ordhl, C. P. 1991. Characterization of a promoter element required for transcription in myocardial cells. J. Biol. Chem. 266, 3309-3316.
14. Kelly, R., Alonso, S., Tajbakhsh, S., Cossu, G. & Buckingham, M. 1995. Myosin light chain 3F regulatory sequences confer regionalized cardiac and skeletal muscle expression in transgenic mice. J. Cell Biol. 129, 383-396.
15. Klamut, H. J., Gangopadhyay, S. B., Worton, R. G. & Ray, P. N. 1990. Molecular and functional analysis of the muscle-specific promoter region of the Duchenne muscular dystrophy gene. Mol. Cell. Biol. 10, 193-205.
16. Koenig, M., Hoffman, E. P., Berteison, C. J., Monaco, A. P, Feener, C. & Kunkel, L. M. 1987. Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell 50, 509-517.
17. Lidov, H. G. W., Byers, T. J. & Kunkel, L. M. 1993. The distribution of dystrophin in the murine central nervous system: An immunocytochemical study. Neuroscience 54, 167-187.
18. Mar, J. H. & Ordahl, C. P. 1990, M-CAT binding factor, a novel trans-acting factor governing muscle-specific transcription. Mol. Cell. Biol. 10, 4271-4283.
19. Milasin, J., Muntoni, F., Severini, G. M. et al. 1996. A point mutation in the 5'splice site of the dystrophin gene first intron responsible for X-linked dilated cardiomyopathy. Hum. Mol. Genet. 5, 73-79.
20. Muntoni, F., Cau, M., Ganau, A. et at. 1993. Deletion of the dystrophin muscle-promoter region associated with X-linked dilated cardiomyopathy. N. Engl. J. Med. 329, 921-925.
21. Muntoni, F., Wilson, L., Marrosu, G. et al. 1995. A mutation in the dystrophin gene selectively affecting dystrophin expression. J. Clin. Invest. 96, 693-699.
22. Nakatsuji, Y., Hidaka, K., Tsujino, S. et al. 1992. A single MEF-2 site is a major positive regulatory element required for transcription of the muscle-specific subunit of the human phosphoglycerate mutase gene in skeletal and cardiac muscle cells. Mol. Cell. Biol. 12, 4384-4390.
23. Navankasattusas, S., Zhu, H., Garcia, A. V., Evans, S. M. & Chein, K. R. 1992. A ubiquitous factor (Hf-1a) and a distinct muscle factor (Hf-1b/MEF-2) form an E-box-independent pathway for cardiac muscle gene expression. Mol. Cell. Biol. 12, 1469-1479.
24. Ommen, G. J. B. V., Ginjaar, H. B., Casula, L. et al. 1991. From dystrophy to dystrophin: Tracing back structure to (dys) function. In: Third Uehara Memorial Symposium: Frontier of Muscle Research (Ed. E. Ozawa), pp. 381-394. Elsevier, Amsterdam.
25. Pari, G., Jardin, K. & McBurnney, M. W. 1991. Multiple CarG boxes in the human cardiac actin gene promoter required for expression in embryonic cardiac muscle cells developing in vitro from embryonal carcinoma cells. Mol. Cell. Biol. 11, 4796-4803.
26. Perloff, J. K., Leon, A. C. J. D. & O'Doherty, D. 1966. The cardiomyopathy of progressive muscular dystrophy. Circulation 33, 625-648.
27. Prior, T. W., Papp, A. C., Snyder, P. J. et al. 1993. A missense mutation in the dystrophin gene in Duchenne muscular dystrophy patient. Nature Genet. 4, 357-360.
28. Ross, R. S., Navankasattusas, S., Harvey, R. P. & Chien, K. R. 1996. An HF-1a/HF-1b/MEF-2 combinatorial element confers cardiac ventricular specificity and establishes an anteriorposterior gradient of expression. Development 122, 1799-1809.
29. Rugh, R. 1968. The Mouse. Burgess Publishing, Minneapolis, USA.
30. Sartorelli, V., Hong, N. A., Bishopric, N. H. & Kedes, L. 1992. Myocardial activation of the human cardiac α-actin promoter helix- loop-helix proteins. Proc. Natl Acad. Sci. USA 4, 4047-4051.
31. Towbin, J. A., Hejtmancik, J. F., Brink, P., Gelb, B., McCabe, E. R. B. & Swift, M. 1993. X-linked dilated cardiomyopathy, molecular genetic evidence of linkage to the Duchenne muscular dystrophy (dystrophin) gene at the Xp21 locus. Circulation 87, 1854.
32. Wassarman, P. M. & DePamphilis, M. L. 1993. Methods in enzymology: Guide to techniques in mouse. Development 225, 468-469.
33. Yamamura, K. I., Kikutani, H., Takahashi, N. et al. 1984. Introduction of human γ1 immunoglobulin genes into fertilized mouse eggs. J. Biochem. 96, 357-363.
34. Yoshida, K., Ikeda, S., Nakamura, A. et al. 1993. Molecular analysis of the Duchenne muscular dystrophy gene in patients with Becker muscular dystrophy presenting with dilated cardiomyopathy. Muscle Nerve 16, 1161-1173.